Southeast Asia Healthcare, Pharmaceuticals & Life Sciences

Hong Le

Hong Le

GSK Vietnam

Legal Director, Vietnam

Interview

What are the key projects you have been involved in over the past twelve months?

The past twelve months have been a pivotal period for the healthcare and pharmaceutical sector in Vietnam, with significant regulatory and policy changes reshaping the operating environment. My primary focus has been helping the business anticipate, interpret and respond to these developments in a way that creates sustainable competitive advantage while maintaining the highest standards of compliance.

One of the most impactful initiatives I led was the development of an integrated legal and policy strategy to navigate evolving healthcare regulations and unlock earlier patient access to innovative medicines and vaccines. Rather than viewing regulatory change as a compliance challenge, I worked closely with cross-functional leaders to identify opportunities where policy developments could be translated into tangible patient and business outcomes.

A key achievement was establishing a structured governance and decision-making framework that accelerated product launch readiness and market access activities. By aligning among the key stakeholders around a common roadmap, we were able to significantly streamline internal and external processes and remove bottlenecks that traditionally delay launches.

As a result, the organisation was able to accelerate certain launch activities by approximately 18 months compared to the conventional pathway. This enabled patients to gain earlier access to important treatment options while strengthening the company's growth trajectory in Vietnam.

In parallel, I provided strategic legal leadership on multiple business-critical initiatives involving evolving regulatory requirements, healthcare professional engagement frameworks, digital transformation projects, data privacy developments, and complex stakeholder partnerships. My role extended beyond legal risk management to helping business teams identify compliant pathways to innovate in a rapidly changing environment.

Another area of focus was enhancing Vietnam's readiness for the implementation of emerging data protection and healthcare compliance requirements. Through proactive risk assessments, governance improvements and targeted training, we strengthened the organisation's ability to operate confidently amidst increasing regulatory complexity.

Throughout these projects, my objective has been to position the legal function as a strategic enabler of innovation, helping the business make bold but responsible decisions that ultimately benefit patients, healthcare systems and society.

Please provide a brief overview of any internal transformation or development initiatives within your legal team over the past twelve months.

Over the past year I have focused on transforming the legal function from a traditional risk-management role into a strategic partner that actively supports business growth and innovation.

One major initiative involved introducing AI-enabled ways of working to improve efficiency in contract review, policy analysis, legal research and in-house knowledge management. By combining technology with robust human oversight, the team has been able to reduce administrative work and redirect capacity toward higher-value strategic advisory activities.

I also led the development of practical contract templates, streamlined governance processes, and decision-making frameworks that empower business teams while ensuring consistent compliance standards. These tools have improved agility, increased transparency and reduced turnaround times for routine matters.

Recognising that regulatory change remains one of the most significant challenges in the healthcare sector, the team invested heavily in proactive horizon scanning and stakeholder engagement. We established stronger mechanisms to identify upcoming policy developments, assess potential impacts and prepare business leaders well in advance.

In addition, we strengthened cross-functional collaboration between legal, compliance, regulatory, medical, finance, HR and commercial teams. This integrated approach has helped ensure that legal considerations are embedded earlier in business planning, resulting in faster, better-informed decisions.

The outcome has been a more agile, business-focused legal function that delivers measurable commercial value while maintaining strong governance and ethical standards.

How do you use AI within your legal team to improve efficiency while maintaining the ‘human-in-the-loop’ element?

I view AI as an accelerator rather than a replacement for legal judgment.

Within the legal function, AI is used to support activities such as document review, “chat-bot” for basic corporate info, contract analysis, legal research, drafting support. These tools help reduce repetitive administrative tasks and enable lawyers to focus on strategic decision-making and complex risk assessments.

However, every legal conclusion, recommendation and risk assessment remains subject to human review. We maintain a clear "human-in-the-loop" principle whereby AI-generated outputs are treated as drafts or inputs rather than final advice. Lawyers remain accountable for validating accuracy, assessing context, applying legal judgment and ensuring compliance with professional obligations.

This balance allows us to capture the efficiency benefits of technology while preserving the critical thinking, ethical judgment and business understanding that define the value of in-house counsel.

With increasing regulatory complexity across jurisdictions, how do you embed compliance throughout the business and ensure consistent standards across different regions?

I believe compliance is most effective when it is integrated into business decision-making rather than operating as a separate control function.

My approach focuses on translating complex legal requirements into practical business actions. This involves close engagement with leadership teams, developing clear governance frameworks, and ensuring accountability is embedded across functions.

In Vietnam, the pace of legislative change has accelerated significantly in recent years. To address this, I established mechanisms for ongoing policy monitoring, impact assessment and proactive stakeholder engagement. This enables the organisation to anticipate regulatory developments rather than respond reactively.

Consistency is achieved through a combination of global standards, local risk assessments, targeted training and cross-functional collaboration. By creating a culture where compliance is viewed as a source of trust and sustainable growth, organisations can achieve both business performance and regulatory excellence.

How do you help drive strong governance and ethical decision-making across your organisation?

Strong governance begins with culture.

As Legal Director, I see my role not only as providing legal advice but also as helping leaders make decisions that align with the organisation's values and long-term responsibilities.

I encourage early engagement with legal and compliance teams, creating an environment where difficult questions are discussed openly before risks materialise. This allows the organisation to consider not only whether an action is legally permissible, but also whether it is ethically appropriate and sustainable.

I also promote practical risk-based decision-making. Rather than focusing solely on theoretical legal risks, we evaluate potential impacts on patients, healthcare professionals, regulators, employees and society. This broader perspective helps leaders make balanced decisions that protect both business performance and organisational reputation.

Ultimately, strong governance is achieved when ethical considerations become embedded in everyday decision-making rather than being treated as a separate compliance exercise.